23rd International Conference on Cancer Research & Pharmacology
- hace 6 años
23rd International Conference on Cancer Research & Pharmacology
At
Edinburgh
For more information: https://www.eventbrite.com/e/23rd-international-conference-on-cancer-research-pharmacology-pgr-as-tickets-38773153546?aff=RMV
DESCRIPTION
==============
About Conference
PULSUS group is glad to invite all the participants across the globe to attend ‘23rd International conference on Cancer Research & Pharmacology’ during March 26-27, 2018 in Edinburgh, Scotland which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.
Why to attend??
================
This cancer conferences will enlighten the public with recent advances in Cancer diagnosis and therapy from around the world and to sharpen the related ideas about cancer research. Moreover this oncology conferenceprovides you a great networking with peers. World-renowned speakers, the most recent techniques, and the newest updates in cancer research fields are the trademark of this conference. Cancer conferences, symposiums and Workshops provide a dedicated forum for the advancement, execution and exchange of information about Oncology and Cancer.
Cancer Research 2018 is a hallmark in the era of cancer conferences with its eminent speakers and notable organizing committee members.
For more information: https://www.eventbrite.com/e/23rd-international-conference-on-cancer-research-pharmacology-pgr-as-tickets-38773153546?aff=RMV
Who should attend??
=====================
Oncologists, Radiologists, Chemotherapists, Physicians, Academicians, Academic scientists, Industry professionals, Diagnostic laboratory professionals, Undergraduate & Postgraduate students, researchers, business professionals, Postdoctoral fellows and Trainees, Cancer Diagnostics Associations and Societies.
Importance & Scope:
Cancer Research 2018 conference provides the best platform for the experts, researchers, students and business delegates with its well organized scientific program including detail information about the current scenario of cancer research and the advancement
At
Edinburgh
For more information: https://www.eventbrite.com/e/23rd-international-conference-on-cancer-research-pharmacology-pgr-as-tickets-38773153546?aff=RMV
DESCRIPTION
==============
About Conference
PULSUS group is glad to invite all the participants across the globe to attend ‘23rd International conference on Cancer Research & Pharmacology’ during March 26-27, 2018 in Edinburgh, Scotland which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.
Why to attend??
================
This cancer conferences will enlighten the public with recent advances in Cancer diagnosis and therapy from around the world and to sharpen the related ideas about cancer research. Moreover this oncology conferenceprovides you a great networking with peers. World-renowned speakers, the most recent techniques, and the newest updates in cancer research fields are the trademark of this conference. Cancer conferences, symposiums and Workshops provide a dedicated forum for the advancement, execution and exchange of information about Oncology and Cancer.
Cancer Research 2018 is a hallmark in the era of cancer conferences with its eminent speakers and notable organizing committee members.
For more information: https://www.eventbrite.com/e/23rd-international-conference-on-cancer-research-pharmacology-pgr-as-tickets-38773153546?aff=RMV
Who should attend??
=====================
Oncologists, Radiologists, Chemotherapists, Physicians, Academicians, Academic scientists, Industry professionals, Diagnostic laboratory professionals, Undergraduate & Postgraduate students, researchers, business professionals, Postdoctoral fellows and Trainees, Cancer Diagnostics Associations and Societies.
Importance & Scope:
Cancer Research 2018 conference provides the best platform for the experts, researchers, students and business delegates with its well organized scientific program including detail information about the current scenario of cancer research and the advancement